Randomized study comparing effects of oral hypoglycemic agents (nateglinide, acarbose) on daily glucose profile analyzed by 24-hour continuous glucose monitering system
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000002995
- Lead Sponsor
- Third Department of Intenal Medicine, University of Yamanashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe ketosis, diabetic coma or semicoma 2. Severe infectious disease, pre- or post-surgical operation, severe injury. 3. Allergy to acarbose or nateglinide 4. Pregnant or lactation period 5. Sever liver or kidney failure 6. Overt obesity (BMI>40)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Daily profiles of glucose level in patients to whom acarbose or nateglinide is administered.
- Secondary Outcome Measures
Name Time Method